Arbutus Biopharma (ABUS) Current Deferred Revenue (2010 - 2025)
Arbutus Biopharma (ABUS) reported Current Deferred Revenue of $6.76 million for Q1 2025, down 41.5% from $11.55 million a year earlier and down 10.7% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2024, Arbutus Biopharma posted Current Deferred Revenue of $7.57 million, down 35.8% from FY2023.
- By year, Current Deferred Revenue came in at $11.79 million in FY2023 (-28.3%) and $16.46 million in FY2022.
- The Q1 2025 figure ranks as the lowest quarterly Current Deferred Revenue since Q3 2018.
- Year over year, Current Deferred Revenue has now declined in each of the last nine quarters, with an average decline of 24.4% over the last eight quarters.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 9.7% (Q2 2023) to 41.5% (Q1 2025).
- Per Business Quant data, the three quarters before Q1 2025 came in at $7.57 million (Q4 2024), $10.91 million (Q3 2024) and $11.03 million (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Arbutus Biopharma | 755.33 Mn | 382.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 6.76 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 10.91 Mn |
| Jun 30, 2024 | 11.03 Mn |
| Mar 31, 2024 | 11.55 Mn |
| Dec 31, 2023 | 11.79 Mn |
| Sep 30, 2023 | 12.11 Mn |
| Jun 30, 2023 | 15.33 Mn |
| Mar 31, 2023 | 15.06 Mn |
| Dec 31, 2022 | 16.46 Mn |
| Sep 30, 2022 | 14.88 Mn |
| Jun 30, 2022 | 16.97 Mn |
| Mar 31, 2022 | 23.26 Mn |
| Sep 30, 2018 | 649,000.00 |
| Jun 30, 2018 | 974,000.00 |
| Mar 31, 2018 | 1.72 Mn |
| Dec 31, 2017 | 2.74 Mn |
| Sep 30, 2017 | 15,000.00 |
| Jun 30, 2017 | 2.62 Mn |
| Mar 31, 2017 | 2.62 Mn |
API Access
Arbutus Biopharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();